Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491

BACKGROUND: Despite new therapeutic approaches have improved the prognosis of newborns with retinopathy of prematurity (ROP), an unfavourable structural and functional outcome still remains high. There is high pressure to develop new drugs to prevent and treat ROP. There is increasing enthusiasm for...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippi, Luca, Cavallaro, Giacomo, Fiorini, Patrizio, Daniotti, Marta, Benedetti, Valentina, Cristofori, Gloria, Araimo, Gabriella, Ramenghi, Luca, Torre, Agostino La, Fortunato, Pina, Pollazzi, Liliana, Marca, Giancarlo la, Malvagia, Sabrina, Bagnoli, Paola, Ristori, Chiara, Monte, Massimo Dal, Bilia, Anna Rita, Isacchi, Benedetta, Furlanetto, Sandra, Tinelli, Francesca, Cioni, Giovanni, Donzelli, Gianpaolo, Osnaghi, Silvia, Mosca, Fabio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993687/
https://www.ncbi.nlm.nih.gov/pubmed/21087499
http://dx.doi.org/10.1186/1471-2431-10-83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993687/
https://www.ncbi.nlm.nih.gov/pubmed/21087499
http://dx.doi.org/10.1186/1471-2431-10-83

Ejemplares similares